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Summary 
Transient receptor potential melastatin 8 (TRPM8) is the principal cold and menthol 
receptor channel. Characterized primarily for its cold sensing role in sensory 
neurons, it is expressed and functional in several non-neuronal tissues, including 
vasculature. We previously demonstrated that menthol causes variable mechanical 
responses (vasoconstriction, vasodilatation or biphasic reactions) in isolated arteries, 
depending on vascular tone. Here we aimed to dissect the specific ion channel 
mechanisms and corresponding Ca2+ signalling pathways underlying such complex 
responses to menthol and other TRPM8 ligands in rat tail artery myocytes using 
patch-clamp electrophysiology, confocal Ca2+ imaging and ratiometric Ca2+ 
recording. Menthol (300 μM, a concentration typically used to induce TRPM8 
currents) strongly inhibited L-type Ca2+ channel current (L-ICa) in isolated myocytes, 
especially it’s sustained component, most relevant for depolarisation-induced 
vasoconstriction.  In contraction studies, with nifedipine present (10 μM) to abolish L-
ICa contribution to phenylephrine (PE)-induced vasoconstrictions of vascular rings, a 
marked increase in tone was observed with menthol, similarly to resting (i.e. without 
α-adrenoceptor stimulation by PE) conditions, when L-type channels were mostly 
deactivated. Menthol-induced increases in PE-induced vasoconstrictions could it be 
inhibited both by the TRPM8 antagonist  AMTB (thus confirming specific role of 
TRPM8), and by cyclopiazonic acid treatment to deplete Ca2+ stores, pointing to a 
major contribution of Ca2+-release from the sarcoplasmic reticulum in these 
contractile responses. Immunocytochemical analysis has indeed revealed co-
localisation of TRPM8 and InsP3 receptors . Moreover, menthol Ca2+ responses, 
which were somewhat reduced under Ca2+-free conditions, were strongly reduced by 
cyclopiazonic acid treatment to deplete Ca2+ store, while caffeine-induced Ca2+ 
responses were blunted in the presence of menthol.  Finally, two other common 
TRPM8 agonists, WS-12 and icilin, also inhibited L-ICa. With respect to L-ICa 
inhibition, WS-12 is the most selective agonist. It augmented PE-induced 
contractions, while any secondary phase of vasorelaxation (as with menthol) was 
completely lacking. Thus, TRPM8 channels are functionally active in rat tail artery 
myocytes and play a distinct direct stimulatory role in control of vascular tone. 
However, indirect effects of TRPM8 agonists, which are unrelated to TRPM8, are 
mediated by inhibition of L-type Ca2+ channels, and largely obscure TRPM8-
mediated vasoconstriction.  These findings will promote our understanding of 
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vascular TRPM8 role, especially the well known hypotensive effect of menthol, and 
may also have certain translational implications (e.g. in cardiovascular surgery, 
organ storage and transplantation, Raynaud’s phenomenon).  
 
 
New & Noteworthy 
Although the cold and menthol receptor, calcium-permeable TRPM8 channel is 
expressed in vascular smooth muscles, surprisingly menthol causes vasorelaxation. 
Here we dissect the true contractile response of rat tail artery myocytes to TRPM8 
activation, which is normally “masked” by the nonspecific inhibition of voltage-
activated L-type calcium channels resulting in vasorelaxation.   
 
 
 
Key words: TRPM8 agonists, voltage-gated Ca2+ channels, vasodilatation, 
vasoconstriction 
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AMTB, N-(3-aminopropyl)-2-{[(3-methylphenyl)methyl]oxy}-N-(2-thienylmethyl)-
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L-type voltage-gated Ca2+ channel; PE, phenylephrine; PSS, physiological salt 
solution; RyR, ryanodine receptor; SERCA, sarco/endoplasmic reticulum Ca2+-
ATPase; SR, sarcoplasmic reticulum; TRP, transient receptor potential; TRPM, 
transient receptor potential melastatin; VGCC, voltage-gated Ca2+ channel; VSM, 
vascular smooth muscle; VSMC, vascular smooth muscle cell. 
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Introduction 
Transient receptor potential melastatin member 8 (TRPM8) is an cation 
channel best known for its role in sensory nerve endings where it is activated by cold 
temperatures and cooling compounds, such as menthol and icilin (23, 25, 27).  In 
nerve terminals, TRPM8 channel opening initiates membrane depolarization 
accompanied by an acceleration of action potential discharge that ultimately result in 
the perception of environmental cold (3, 23). Although the role of TRPM8 is now well 
established as the primary sensor of thermal stimuli in the innocuous cold range (3, 
12, 13), with a temperature threshold of ~26°C (25), the channel was first cloned and 
identified in prostate epithelia and several types of carcinoma (38), tissues in which 
temperature would not be expected to deviate substantially from that of the core 
body temperature. TRPM8 expression has now been found in several non-neuronal 
tissues including the bladder and male genital tract (34), lung epithelia (32), and in 
the vasculature (16, 17, 26, 35, 42, 43). Additionally, numerous endogenous 
molecules have been proposed to increase (phosphatidylinositol 4,5-biphosphate 
and lysophospholipids; 1, 2, 20, 30) and decrease (arachidonic acid; 2, 5) TRPM8 
activity and enzymes protein kinase A and protein kinase C have been proposed to 
regulate TRPM8 by altering its phosphorylated state (4, 5, 30), thus providing 
putative endogenous biochemical modulatory pathways for TRPM8, distinct from 
thermal stimuli. These findings raise important questions as to the whole spectrum of 
expression and functions of this truly polymodal protein that forms Ca2+-permeable 
cation channels. 
There is strong evidence to indicate TRPM8 gene expression in rat and 
mouse vascular smooth muscle (VSM; 17, 35, 42, 43). As a Ca2+-permeable cation 
channel (PCa/PNa~1-3; 25, 27), activation of TRPM8 located on the plasma 
membrane and/or the membrane of the sarcoplasmic reticulum (SR) of these VSM 
cells (VSMC) would be expected to induce increased intracellular Ca2+ ([Ca2+]i).  In a 
study by Yang et al. (43), the application of menthol (300 μM) to transiently cultured 
rat aortic and pulmonary VSMCs resulted in the expected robust increases in [Ca2+]i 
that were dependent on the presence of extracellular Ca2+ and could be blocked by 
the non-selective cation channel inhibitor Ni2+ (300 μM), while the L-type voltage-
gated Ca2+ channel (L-VGCC) blocker nifedipine (1 μM) had no effect (43). These 
findings indicated that menthol-induced responses in rat aortic and pulmonary 
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VSMCs were entirely mediated by Ca2+ influx, suggesting TRPM8 expression on the 
plasma membrane of these cells. 
In our earlier work we used an organ bath tensiometric preparation along with 
TRPM8 pharmacological modulators, menthol and icilin, as well as KCl and the α1-
adrenoceptor agonist, phenylephrine (PE), in order to observe the consequences of 
putative TRPM8 activation on the tone of vascular rings, from several major arteries 
and during different contractile states (17).  From these functional experiments, we 
observed complex effects of TRPM8 agonists on vascular contractility, causing 
prominent vasodilatations when applied during PE- and high-K+-induced 
vasoconstrictions, while menthol (300 µM) consistently caused vasoconstrictions 
when applied to rat tail artery vascular rings at rest. These are disparate effects as 
menthol-induced activation of TRPM8 would be expected to invariably induce VSM 
contraction by its virtue of raising [Ca2+]i (43). To add to the puzzle, systemic and 
chronic dietary administration of menthol is known to have a pronounced 
hypotensive effect (30, 35), and in our earlier study we also observed vasodilation of 
cutaneous blood vessels in vivo after topical menthol application (17). Such 
observations strongly imply that there may be other targets for menthol action on 
blood vessels, apart from TRPM8, for which it is presumed to be a selective agonist 
that can only be expected to cause Ca2+ mobilisation and vasoconstriction.  
Menthol-induced vasorelaxation has been corroborated in a more recent 
study that systematically investigated this effect in different rat vascular beds (aortae, 
mesenteric and coronary arteries) and confirmed its wide-spread existence 
throughout the vascular system. In this study, Cheang et al. (10) hypothesised that 
such effect could be explained by the dominant menthol inhibition of VGCC, 
activation of which normally initiates and maintains VSM contraction during 
membrane depolarisation, and provided Ca2+-imaging and pharmacological evidence 
for this hypothesis. In this context, it should be noted that (i) smooth muscle and 
cardiac VGCC are molecularly similar (the principal transmembrane subunit α1 is 
CaV1.2 type; (9), and (ii) there is direct patch-clamp evidence for menthol-induced 
inhibition of cardiac L-type VGCC that occurs at concentrations which normally 
activate TRPM8 (IC50=75 µM; (6). However, the hypothesis does not address the 
entire complexity of menthol action on vascular smooth muscles, as it contradicts 
measurements of [Ca2+]i  rises and vascular contractions of non-stimulated VSM and 
blood vessels induced by TRPM8 agonists (17, 43). Moreover, even in pre-
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constricted vascular rings menthol induces notable initial contraction preceding 
relaxation (17). Thus, in the present study, our aims were (i) to identify the effects of 
TRPM8 agonists (mainly menthol as the most widely used one, and especially 
interesting as a common ingredient in many medicines and consumer products), on 
vascular tissues using a range of physiological and biophysical techniques and a 
much more rigorous set of experiments than previously used aiming to dissect the 
specific TRPM8-mediated effects, (ii) to further test the hypothesis that TRPM8 is 
functional in rat tail artery VSM but that the consequences of TRPM8 activation may 
be masked by non-specific effects of TRPM8 agonists, most likely on VGCC, and (iii) 
to directly test this latter possibility by patch-clamp measurements of L-type Ca2+ 
channel currents. 
Some of the results have been communicated in an abstract form (24). 
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Methods 
Ethical approval - All experimental procedures involving animals were in accordance 
with UK Animal Scientific Procedures Act (1986) and were approved by the Queen’s 
University and University of Liverpool Animal Welfare and Ethics Committees. 
 
Animal tissue - Experiments were performed on vessels freshly dissected from 8- to 
12-wk-old male Sprague-Dawley rats. Tail arteries were removed from the whole 
length of the tail. The proximal 2–3 cm of the artery was taken for tensiometric 
studies, and the rest was used for smooth muscle isolation followed by Ca2+ 
measurement or patch clamp analysis.  
 
Vascular smooth muscle isolation - Excised tail arteries were transferred to Ca2+-free 
physiological salt solution (PSS) containing the following (in mM): 120 NaCl, 6 KCl, 
1.2 MgCl2, 10 HEPES, and 12 glucose, pH 7.4 (adjusted with NaOH). The artery was 
cleaned free of connective tissue and longitudinally cut. The endothelium was 
removed by gently rubbing of the luminal surface with fine stainless steel wire.  The 
tissue was then sectioned into 5-mm lengths before being transferred to dissociation 
medium (DM) containing the following (in mM): 110 NaCl, 5 KCl, 0.5 KH2PO4, 0.5 
NaH2PO4, 10 Na2HCO3, 10 HEPES, 10 taurine, 0.5 EDTA, 10 glucose, 2 MgCl2, and 
0.16 CaCl2, pH 7.4 (adjusted with NaOH). The tissue was digested at 37°C for 20 
min in DM containing collagenase (type XI; 1 mg/ml), papain (1 mg/ml), BSA (0.4 
mg/ml), and dithiothreitol (0.8 mM) and was then washed with Ca2+-free PSS to stop 
digestion. Single myocytes were dispersed by trituration with a small-bore glass 
pipette. 
 
Electrophysiology - Isolated vascular myocytes were plated in a CoverWell perfusion 
chamber (Grace Bio-Labs, Sigma-Aldrich Ltd, Dorset, UK) pressed-to-seal to glass 
coverslips and placed on the stage of an inverting microscope (Nikon Eclipse 
TE2000-S, Nikon Corp., Tokyo, Japan). 10 minutes prior to commencement of 
experiments, the cells were superfused with a modified PSS containing (in mM): 
NaCl 120, CsCl 6, HEPES 10, MgCl2 1.2, glucose 12, CaCl2 5, pH 7.4 at room 
temperature.   
Borosilicate glass pipettes (Harvard Apparatus Ltd., UK) were fabricated and 
fire-polished to resistances of 3-4 MΩ and were back-filled with pipette solution 
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containing (in mM): 80 CsCl, 2 MgCl2, 11 EGTA, 7 Na2ATP, 0.5 Na2GTP, 10 
HEPES, and 5 creatine (pH 7.3 adjusted with CsOH).  Pipette electrodes were 
mounted on a CV203BU head-stage connected to a patch clamp amplifier (Axopatch 
200B, Molecular Devices, Union City, CA, USA).  Whole-cell currents were filtered at 
2 kHz (8-pole low-pass Bessel) and sampled at 5 kHz.   
To determine the presence of a persistent Ca2+ current (L-ICa) through VGCCs 
(i.e. the so-called non-inactivating “window current” that occurs in specific range of 
potentials as an important determinant of vascular tone) in the tail artery VSMCs, a 
double-pulse voltage protocol was employed with a constant depolarising test 
potential to 10 mV, preceded by a variable amplitude prepulse ranging from -100 to 
40 mV with a 10 mV increment (see upper panel of figure 1A).   
A custom-made solution delivery system consisting of 8 pressurized 
reservoirs attached to an 8 channel solution delivery pen (AutoMate Scientific, 
Berkeley, CA, USA) with a single outlet needle (250 μm internal diameter; AutoMate 
Scientific) was used for fast solution application. The needle outlet was positioned in 
close proximity (0.1-0.5 mm) to the recorded cell and was used to superfuse the cell 
with the test compound (“bath solution”, “vehicle” or “drug”) until a steady-state 
response had been attained. In addition, a gravity-driven solution exchange attached 
to one side of the bath and vacuum to the other ensured fast and complete removal 
of test compounds from the perfusion chamber. 
To investigate the direct effects of TRPM8 agonists on calcium currents, L-ICa 
was activated by applying 400 ms depolarizing pulses to a test potential of 10 mV 
from a holding potential of -60 mV at 10 s intervals. L-ICa parameters were measured 
as the peak inward current (L-ICa-Peak) achieved soon after the start of the 
depolarizing pulse and as the late non-inactivating current (L-ICa-Late) measured as 
the mean current during the final 10 ms of the 400 ms pulse. To allow quantitative 
comparison of experimental conditions, all currents were normalised such that L-ICa-
Late measured following 30 seconds incubation in nifedipine (10 µM) was set as 
baseline current for each cell studied. 
 
Ratiometric Ca2+ recording – Isolated cells in low-Ca2+ PSS were loaded with Fura-2-
AM (final concentration: 5 μM; Molecular Probes Inc, Invitrogen) and pluronic acid 
(final concentration: 2.5 mg/ml; Sigma-Aldrich) dissolved in DMSO for 25-30 minutes 
in a glass-bottomed recording chamber.  Cells were washed with low-Ca2+ PSS after 
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the loading period for up to an hour at room temperature to allow de-esterification of 
the dye. A gravity-driven continuous flow of PSS ([Ca2+] = 2 mM) was used to 
superfuse the preparation for 10 minutes prior to experiment commencement, with 
excess solution removed by a suction line. 
 A photometric system consisting of an inverted microscope (Olympus IX50, 
Olympus UK Ltd., London, UK) and a Cairn monochromator (Cairn Research Ltd., 
Faversham, UK) with dual excitation (340 and 380 nm) were used to study [Ca2+]i 
responses and their temporal characteristics in rat tail artery VSMCs upon the 
application of various pharmacological agents. Signals were recorded using a ×60 oil 
immersion objective (N.A. 1.3) and emitted fluorescence was measured at 510 nm 
from the side port of the microscope, via an adjustable rectangular window that 
allowed isolation of a region of interest around a selected cell. Acquisition software 
(pClamp 9, Molecular Devices Inc., CA, USA) was used for analysis and on-line 
computation of the F340/F380 ratio. 
 
Laser confocal Ca2+ imaging – similarly to Fura-2, the AM ester derivative of Fluo-3 
(Fluo-3 AM, Invitrogen), with the addition of pluronic acid, was used to monitor Ca2+ 
signals in isolated myocytes using a laser-scanning confocal microscope (MR-A1, 
Bio-Rad laboratories, CA, USA) coupled to an inverted microscope (Nikon Eclipse 
TE300, Nikon Corp., Tokyo, Japan). On this system images were collected at one 
frame per second via oil-immersion objectives (×40, N.A. 1.4; and ×60, N.A. 1.4). 
The Fluo-3 dye was excited by an argon laser at 488 nm and emitted light was 
filtered through a 530-560 nm band-pass filter and detected using a photomultiplier 
tube. Data acquisition was controlled with Lasersharp software (Biorad, CA, USA) 
and analysis was performed using EZ-C1 FreeViewer software (Nikon Corp., Tokyo, 
Japan). In addition, fast Ca2+ imaging was performed using an Ultraview LCI 
spinning Nipkow disc, widefield Olympus IX70 inverted microscope (Perkin-Elmer 
Confocal Microscope System, Cambridge, UK), with a high sensitivity, Orca-ER 
cooled CCD camera (Hamamatsu Photonics, Hamamatsu, Japan) to capture emitted 
fluorescence.  Images were collected at a rate of 33 frames per second via a ×60 
water immersion objective (NA 1.2) with fluo-4 loaded cells excited by an argon laser 
at 488 nm and emitted fluorescence measured at 510 nm.  Data acquisition and 
analysis were performed using Perkin-Elmer Microscope System software. 
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Contraction studies – Tail artery sections with endothelium removed had mechanical 
responses recorded as previously described (17). The condition of the tissue was 
initially tested by adding KCl (60 mM) and rejecting tissue that did not respond with a 
robust contraction (>0.5 g tension). One of three basic protocols was then 
conducted. 1) Vessels were examined for a contractile response to menthol alone 
(0.1-1 mM; experiment performed at room temperature). 2) Vessels were contracted 
with PE (2 µM) and menthol (300 µM) was added during contraction (having allowed 
10 min for contraction to stabilize).  3) To eliminate the involvement of L-type VGCC 
in TRPM8 agonist-induced responses vessels were incubated with the L-type VGCC 
antagonist nifedipine (10 µM) for 10 minutes prior to repeating the second protocol. 
Vascular responses to TRPM8 agonist application were measured as the peak 
constriction induced (peak response) and the tone remaining 10 minutes after 
application (late response) relative to PE-induced tone immediately prior, as 
illustrated in Fig. 4B. Experiments examining the effects of WS-12 (50 µM) were 
performed and data analysed in the same manner.  All summary data presented 
have been normalized to the PE-vasoconstriction amplitude 10 minutes after PE 
application.   
To determine the specificity of the menthol-induced responses, tail artery 
vascular rings were preincubated with the TRPM8 antagonist N-(3-aminopropyl)-2-
{[(3-methylphenyl)methyl]oxy}-N-(2-thienylmethyl)-benzamide hydrochloride salt 
(AMTB, 10 µM), in addition to nifedipine, for 10  minutes before repeating protocol 3. 
 
Immunocytochemistry – Isolated tail artery VSMCs were fixed in 2 % 
paraformaldehyde (PFA; Sigma-Aldrich) for 4 minutes, washed for 1-1½ hours in 
phosphate buffered saline (PBS), changing solution every 15 minutes, and blocked 
in PBS containing 1 % BSA and 0.05 % triton-X (Invitrogen) for 1 hour (all at room 
temperature). To visualise TRPM8 subcellular localisation, cells were incubated with 
rabbit anti-TRPM8 primary (ACC-049; Alomone Labs, Jerusalem, Israel; dilution of 
1:200) overnight at 4 °C.  Cells were again washed in PBS for 1-1½ hours, before 
being incubated for 1 hour with Alexa Fluor 488 donkey anti-rabbit IgG (A21206; 
Invitrogen Molecular Probes; dilution of 1:200) in the dark.  After a further washing, 
slides were completed by applying Vectashield hard-setting mounting medium 
(Vector labs Inc.) containing 1.5 µg/ml 4',6-diamidino-2-phenylindole (DAPI) to 
counterstain the cell nuclei, and a glass coverslip. Slides were examined using 
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confocal microscopy. In addition, the anti-TRPM8 antibodies were used in 
combination with goat primary antibodies for type I InsP3 receptor (InsP3R1) (sc-
6093; Santa Cruz Biotechnology Inc., CA, USA; dilution of 1:100) and secondary 
Alexa Fluor 594 chiken anti-goat IgG (A21468; Invitrogen Molecular Probes; dilution 
of 1:200)  to determine if co-localisation of TRPM8 and InsP3R1 was evident. 488 nm 
(argon) laser was used to view Alexa 488 staining and 561 nm (HeNe) laser - Alexa 
594 staining. Control experiments were performed by the omission of primary 
antibodies to determine the specificity of the secondary antibody or by the omission 
of both primary and secondary antibodies to detect auto-fluorescence in the cells of 
interest.  
 
Statistical analysis - Data are expressed as mean ± standard error of the mean 
(SEM) with N for the number of animals and n for the number of samples. Statistical 
significance of differences between control and experimental treatments were 
determined using Student’s paired or unpaired t-tests as appropriate or one-way 
ANOVA for multiple comparisons. In contractile experiments, values for each 
condition, i.e. PE after 10 minutes, menthol peak and after 10 minutes (late) were 
compared by one-way ANOVA for repeated measures followed by Tukey’s post hoc 
test.  Peak and late values in control conditions and in the presence of nifedipine 
were compared by Student’s t-test. P values of <0.05 were accepted as statistically 
significant, denoted in the graphs by *; P<0.01 and P<0.001 are denoted as ** and 
***, respectively.  
 
Drugs - All drugs were supplied by Sigma-Aldrich (Dorset, UK), except for AMTB 
(Tocris Bioscience, Abingdon, UK). 
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Results 
ICa in rat tail artery VSMCs and the effects of TRPM8 agonists 
 To investigate parameters of a persistent L-ICa in tail artery VSMCs, eight cells 
were recorded using the double-pulse protocol (mean membrane capacitance 
Cm=42.2±4.0 pF; N=4) and activation (m∞) and inactivation (h∞) curves were 
constructed from peak amplitudes of L-ICa during the pre-pulse and test steps in a 
conventional manner (Fig. 1A,B). The potentials of half-maximal activation and 
inactivation (V1/2) were 3.6±1.6 and -18.9±1.1 mV, with the curves having Boltzmann 
slopes (k) of 15.7±0.6 mV and 9..9±0.7 mV, respectively. Averaged maximal Ca2+ 
conductance of 1.34±0.23 nS and very positive reversal potential of the current, 
55.5±2.9 mV, suggested adequate L-ICa isolation. 
The ‘window current’, which is maximal at the potential of intersection of these 
curves, indicates clearly that a persistent ICa is present over a wide range of 
potentials including within the physiological range of resting potentials in this cell-
type and those achieved during PE action, with peak at about -10 mV (inset in 
Fig.1B).  
After examining the activation/inactivation characteristics of the persistent L-
ICa, a different protocol was used to investigate the direct effects of TRPM8 agonists 
on L-ICa. Menthol has been shown previously to inhibit L-ICa in other cell types, 
namely neurons and cardiac myocytes (6, 36), suggesting, based on molecular 
similarities of channels, the presence of such inhibition in vascular myocytes as well. 
In the present study, using the same menthol concentration (300 µM) as used in our 
previous tensiometric experiments (17), we observed strong inhibitory effects of 
menthol on L-ICa in tail artery VSMCs (Fig. 1C). Following subsequent nifedipine 
application for several minutes, a residual transient current was often observed.  This 
current likely represented Ca2+ influx through T-type VGCCs which are co-expressed 
with L-type channels in a sub-population of rat tail artery VSMCs (28). Inactivation 
kinetics of L-ICa could be well approximated by the sum of two exponentials, and in 
the presence of menthol it was clearly accelerated (e.g. in Fig 1C τfast was reduced 
by menthol from 26.6 to 21.0 ms). Thus, menthol is likely to be a gating modifier, 
rather than a channel blocker that simply hinders the channel pore. 
A time-course plot showing mean peak and late L-ICa for eight cells tested 
(Cm=33.1±1.8 pF; n=8; N=3), under control conditions and in the presence of vehicle-
only or menthol application, is illustrated in Figure 1D. Menthol was found to 
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significantly reduce peak L-ICa by 32.9±2.7 % compared to a 7.6±1.6 % reduction 
induced by the vehicle only control (0.3 % ethanol; P<0.001; n=8; N=3), while the 
late L-ICa was significantly reduced by 67.0±7.0 % compared to a 18.8±5.5 % 
reduction induced by the vehicle only control (P<0.001; n=8; N=3). These findings 
are summarised in Fig. 1E. 
These findings strongly suggest that the vasodilatory effects of menthol on 
pre-constricted vascular rings, as documented previously by Johnson et al. (17) and 
Cheang et al. (10), may largely be accounted for by a direct inhibitory action on 
VGCCs opened by either membrane depolarisation induced by KCl or phenylephrine 
(PE) (hypothesis 1). Fig. 1F shows that, indeed, a substantial part of PE-induced 
contraction is underlined by VGCC activity. 
However, if a major indirect effect of menthol (e.g. non-TRPM8 related) on 
vascular tone is vasorelaxation via the inhibition of VGCCs, it is likely that TRPM8 
channels present in vessel are also activated but that their role in vascular tone is 
masked by the more robust action of L-ICa inhibition. Therefore, to minimise this 
secondary effect ,one method would be to apply menthol to unstimulated VSM, when 
VGCCs are largely closed at resting potential and L-ICa contribution is minimal (see 
“window” current-voltage relation in Fig 1B, inset). As such, the application of 
activators of a Ca2+-permeable ion channel in VSM would be expected to induce an 
increase in [Ca2+]i, according to Yang et al. (42), and vasoconstriction (hypothesis 2). 
Indeed, such vasoconstrictions have been observed previously when menthol was 
applied to pre-tensed rat tail artery sections under resting conditions (17). 
 
Effect of TRPM8 agonists on VSM [Ca2+]i and basal vascular tone 
In rat tail artery VSMCs, menthol induced elevations in [Ca2+]i as well as 
causing concentration-dependent vasoconstrictions in tail artery vascular rings 
(Figs. 2 and 3). Enzymatically isolated VSMCs, loaded with fura-2-AM responded to 
menthol (300 µM) application with robust and reproducible F340/F380 ratio increases, 
responses that were comparable in size to the responses induced by the application 
of sub/supra-maximal concentrations of the ryanodine receptor (RyR) channel 
activator caffeine (1-10 mM) and α1-adrenoceptor agonist PE (2-10 µM) when tested 
in the same cell (Fig. 2A, B). The summary bar chart shows the peak increases in 
F340/F380 (mean ± S.E.M.) induced by caffeine (1 mM: P<0.05, Student’s paired t-test, 
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n=5, N=4; 10 mM: P<0.001, n=14, N=5), PE (2 & 10 μM) and menthol (300 μM), 
relative to basal F340/F380 prior to each compound application (Fig. 2C).  
However, there was one notable difference in the rate of rise of these various 
Ca2+ signals (quantified as time from 10 to 90% of its maximal size, or t10-90), as 
menthol-induced responses were significantly slower compared to caffeine- or PE-
induced responses (Fig. 1D, E). This observation suggests that the density of TRPM-
mediated Ca2+ influx into the cytosol should be considerably lower compared to the 
pathways that involve α1-adrenoceptor and ryanodine receptor activation.Consistent 
with these findings at the cellular level, application of incremental concentrations of 
menthol to pre-tensed, non-constricted tail artery vascular rings at room temperature 
(20-22OC) induced vasoconstrictions that were concentration-dependent (100 µM: 
0.020±0.003 g or 4±1% of KCl vasoconstriction; n=29, N=14; 300 µM: 0.062±0.010 g 
or 10±1 % of KCl; n=29, N=14; NS ; 500 μM: 0.115±0.013 g or 17±2 % of KCl; n=29, 
N=14; 1 mM: 0.339±0.032 g or 52±5 % of KCl; n=29, N=14) and were significantly 
greater than baseline (300 µM – P<0.01; 500 µM – P<0.001; 1 mM – P<0.001; peak 
amplitudes significantly different from zero, one-way ANOVA; Fig. 3). When menthol 
(300 μM) was applied to pre-tensed, relaxed tail artery vascular rings at 37°C 
vasoconstrictions were significantly smaller (0.025±0.004 g or 3±1 % of KCl; n=8, 
N=3; P<0.01; unpaired t-test with Welch’s correction) than those observed at room 
temperature and were more transient in appearance (see Fig. 3A,  inset). These 
results are consistent with synergy between cold and menthol in TRPM8 activation, 
e.g. menthol was shown to activate TRPM8 much more efficiently at 22OC compared 
to 35OC (27). Clearly, menthol mediates Ca2+-mobilising effects sufficient to trigger 
significant vasoconstrictions.   
 
Effect of TRPM8 agonists on vascular tone independent of VGCC activity 
Consistent with the above results, menthol had an initial rapid vasoconstrictive 
effect of variable amplitude when applied during PE-induced vasoconstrictions under 
control conditions (compare Fig. 4A, left panel, Fig. 4B and Fig. 11A, control trace, 
average menthol peak amplitude was 108.4±7.3 % of PE control, P<0.01, one-way 
ANOVA, n=26, N=19), but caused a significant slower vasodilatory effect (Fig. 4A,B). 
The steady-state inhibition of contraction was observed after 10 minutes exposure 
(menthol late) amounted to 73.5±2.4 % of PE control (P<0.001), as illustrated in Fig. 
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4A, left panel and Fig. 4B. We reasoned that if the above described VGCC inhibition 
by menthol (Fig. 1) was indeed involved in the vasorelaxation, prior inhibition of 
VGCC activity by a saturating nifedipine dose (10 µM) should reveal the specific 
TRPM8-mediated component in vascular response. Application of nifedipine 10 
minutes prior to PE resulted in a 46.5±3.0 % reduction of the PE vasoconstriction 
amplitude (Fig. 1F; n=41, N=15), while the application of menthol during nifedipine-
reduced PE vasoconstrictions resulted in significant additional constriction, 
presumably mediated by TRPM8 activation (Fig. 4A, right panel). Under these 
conditions, menthol application induced a peak increase in tone to 163.1±6.0 % of 
the nifedipine-reduced PE control (P<0.001, n=22, N=13) while the tension 
remaining 10 minutes after menthol application (menthol late) was also significantly 
elevated (to 138.4±5.6 %, P<0.001).  When the normalised responses to menthol 
application in control conditions and in the presence of nifedipine were compared, it 
was found that peak and late menthol (% PE control) responses were significantly 
greater in the presence of nifedipine (peak: P<0.001, Student’s paired t-test; late: 
P<0.001) (Fig. 4B, right panel).   
These findings indicate that the most likely mechanism of menthol-induced 
vasodilatation of pre-constricted vessels ((17) and Fig. 4A, left panel) was a direct 
effect on VSM VGCCs, since this effect was reversed in the absence of L-type 
VGCC contribution to PE-vasoconstrictions (Fig. 4A, right panel). Importantly, these 
experiments indicate that the inhibition by menthol of L-ICa, which is more 
pronounced for its late component (Fig. 1E), also likely masks a substantial part of 
the vasoconstrictive effects of the compound even in non-stimulated tissue since 
even at the resting membrane potential considerable “window” Ca2+ current (up to 
40% of maximum) flows (inset, Fig. 1B) contributing to resting vascular tone. 
 
Ca2+ store contribution to menthol-induced vasoconstrictions 
In different cell types, TRPM8 channels can be expressed not only in the 
plasma membrane, where they mediate Ca2+ influx, but also in the endoplasmic 
reticulum, where they promote Ca2+ release from the intracellular stores (1, 7, 8, 32, 
36, 43). In this context, it should be noted that menthol is a membrane permeable 
molecule. In addition, it is possible that TRPM8-mediated Ca2+ influx can trigger 
Ca2+-induced Ca2+ release. To determine whether intracellular Ca2+ stores 
contributed to menthol-induced vasoconstrictions, we inhibited re-uptake of Ca2+ into 
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the sarcoplasmic reticulum (SR) using the sarco/endoplasmic reticulum calcium 
ATPase pump inhibitor cyclopiazonic acid (CPA). When vessels were pre-incubated 
with CPA (10 µM) for 30 minutes prior to a PE-induced vasoconstriction, application 
of menthol (300 µM) 10 minutes later did not induce any increase in tone (peak) as 
was seen in control conditions, but instead, resulted in a more pronounced 
vasodilatation that was significantly greater than seen in the absence of CPA 
(12.2±9.0 % relaxation of PE-vasoconstriction in control conditions compared with 
60.6±6.8 % relaxation in the presence of CPA; P<0.01, Student’s paired t-test; n=8, 
N=8; Fig. 5A,B).  
To strengthen the theory that menthol activation of TRPM8 could result in 
Ca2+ release in tail artery VSMCs to contribute to vasoconstriction, 
immunocytochemistry was performed on isolated tail artery myocytes using a 
specific TRPM8 antibody. A thin, intense immunofluorescence signal on the 
perimeter of the cell was identified, as well as a pronounced signal within the deeper 
cytosol (Fig 5C, left panel). These signals could be attributed to TRPM8 presence at 
plasmalemma and/or sub-plasmalemmal SR in addition to a large intracellular 
structure surrounding the nucleus, most likely the SR. This hypothesis was 
confirmed by the parallel labelling of type I InsP3 receptors (Fig. 5C, middle panel) 
followed by examination of merged images, which revealed such colocalisation of 
TRPM8 and InsP3R, as evident by yellow color in Fig. 5C, right panel. These results 
are consistent with the view that TRPM8 can be localised both on the plasma 
membrane and/or the SR membrane, and mediates Ca2+ influx and/or Ca2+ release 
correspondingly, as in other cell types (1, 7, 8, 32, 35, 37, 44). 
This enhanced vasorelaxation after CPA treatment could, at least in part, be 
attributed a relatively larger contribution of VGCC activity to PE-induced 
vasoconstrictions when SR was dysfunctional. To distinguish between these 
possibilities we next focused on the role of SR in menthol-evoked Ca2+ responses. In 
order to evaluate the relative contribution of VGCC-mediated Ca2+ influx vs Ca2+ 
store release to menthol-evoked intracellular Ca2+ rise, ratiometric Fura-2 
measurements were performed on single myocytes, while VGCC were inhibited by 
nicardipine (5 μM) or Ca2+ store was depleted with CPA (10 µM), respectively. While 
nicardipine had no statistically significant effect, the Ca2+ transients in response to 
menthol were inhibited by 48.9±1.2% (n=3) after Ca2+ store depletion (Fig. 6). It 
should be noted, that this effect of Ca2+ store depletion on the amplitude of menthol-
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induced Ca2+ response is even underestimated since the measured F340/F380 signal 
includes, in addition to the menthol-induced signal, also a more sustained store-
operated Ca2+ entry component, as can be seen in panel Fig. 6C. 
Consistent with this, in confocal Ca2+ imaging experiments performed on 
single Fluo-3 AM loaded myocytes with the use of the MR-A1 system we observed 
significant intracellular Ca2+ rises both with and without external Ca2+, with 
indications of a propagating through the cytosol Ca2+ wave – phenomenon typically 
attributed to Ca2+-induced Ca2+ release process (Fig. 7A-C). On average, in Ca2+-
free PSS the F/F0 signal was reduced from 1.92±0.10 to 1.39±0.03 (n=4; P=0.002) 
indicating that menthol-induced [Ca2+]i rises were due to both Ca2+ entry and Ca2+ 
release.  Moreover, Ca2+ responses to subsequent caffeine application were 
relatively smaller if caffeine was applied in the presence of menthol (F/F0 2.14±0.16 
vs 1.99±0.19 for caffeine and menthol, respectively, n=4; P=0.56), than after menthol 
wash-out (F/F0 2.12±0.26 vs 1.39±0.03 for caffeine and menthol, respectively, n=4; 
P=0.029) (compare Fig. 7A and B). This strongly indicates that menthol, by 
presumably acting on TRPM8 channels expressed on the SE membrane (Fig. 5C), 
reduces the Ca2+ content that be liberated by caffeine. 
To investigate the spatial dynamics of menthol-induced [Ca2+]i rises at a higher 
temporal resolution, we employed the spinning Nipkow disc system. With the 
improved temporal resolution we observed that, indeed, menthol clearly induced a 
propagating through the cytosol Ca2+ wave in  the presence (Fig. 7D, top  panel) and 
the absence (Bottom panel)  of  external  Ca2+ (Figure 7, bottom panel).   Removal of 
external  Ca2+ caused a decrease in  both in  the amplitude and the  velocity of 
propagation of menthol-induced Ca2+ wave, as can be seen by the increased time 
lag between the Fluo-4 signal measured at the initiation (bottom region of  cell)  and 
destination site (top region) of the myocyte (Fig. 7E). 
Effect of TRPM8 antagonist (AMTB) on menthol-induced vasoconstrictions in 
the presence of nifedipine 
We next examined the selectivity of menthol action with regard to TRPM8 
activation, expecting loss of its effect following TRPM8 blockade by AMTB. In the 
presence of AMTB (10 µM), menthol-induced vasoconstrictions in the absence of 
VGCC contribution (Fig. 8A, left panel) were greatly inhibited (right panel). On 
average, in the presence of nifedipine, menthol-induced peak and late 
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vasoconstriction amplitudes that were 173.3±10.3 % and 145.9±9.0 % of the PE 
amplitude, respectively, became significantly reduced to 135.1±6.4 % and 79.5±8.7 
% of the PE control, respectively (peak: P<0.01; late: P<0.001; one-way ANOVA; 
n=9, N=9) when preparations were pre-incubated in nifedipine plus AMTB (Fig. 8B). 
 
Effects of other TRPM8 agonists on ICa in rat tail artery VSMCs 
 In addition to menthol, we examined the effects of two other, more recently 
introduced TRPM8 agonists (icilin and WS-12) on L-ICa in tail artery VSMCs (Fig. 9). 
The concentration of icilin tested was the same as used in our previous tensiometric 
experiments (17) and as deemed sufficient for supramaximal activation of TRPM8 
(50 µM). WS-12 was used at its supramaximal concentration of 50 µM (33). As 
shown in Fig. 9A, both agonists had strong inhibitory effects on L-ICa in these cells. 
Similarly to menthol, iclin accelerate current inactivation of L-ICa (e.g. in Fig 9A τfast 
was reduced by icilin from 32.4 to 25.5 ms). Thus, icilin is also likely to be a VGCC 
gating modifier. 
A time-course showing the effects of vehicle-only and icilin application on peak and 
late L-ICa is illustrated in Fig. 9B. Icilin significantly reduced peak ICa by 35.8±2.6 %, 
compared with a 11.0±1.8 % reduction induced by the vehicle-only control (0.5 % 
DMSO; P<0.001; n=8; N=3), and caused a 78.5±5.7 % inhibition of late ICa compared 
with 17.2±3.0 % by its vehicle-only (P<0.001; Fig 9C). WS-12 induced a 30.0±2.2 % 
reduction in peak L-ICa compared with 16.3±1.7 % by its vehicle-only control (0.5 % 
ethanol; P<0.001), but there was no significant difference between the effects of drug 
and vehicle-only control on late L-ICa (55.3±4.8 % reduction vs. 40.5±4.1 %; Fig. 9D). 
These observations in vascular cells contrast to those in rabbit cardiac myocytes 
where icilin appeared to have no effect on L-ICa (6). 
 The latter observation that WS-12 had little or no effect on the sustained L-ICa 
suggested that this menthol derivative is a more selective TRPM8 agonist compared 
to menthol. We have thus performed similar to the above described Ca2+ ratiometric 
measurements using Fura-2 AM loaded myocytes (Fig. 10) and contractile 
recordings (Fig. 10B, data summarised in Fig. 10C). WS-12 (10 μM) induced robust 
[Ca2+]i rises comparable to those induced by caffeine, PE or menthol (Fig. 10A). 
However, similar to menthol, the rise phase of these responses was much slower 
compared to caffeine- and PE-induced responses, with t10-90=6.16±1.97 s (n=4) 
(compare to Fig. 2E). When applied in the presence of PE WS-12 invariably induced 
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an additional contraction, which was augmented in the presence of nifedipine (Fig. 
10B, C). This indicates, that although some L-ICa occurred (i.e. vehicle only effect in 
case of late L-ICa), the associated relaxation component was masked by a more 
pronounced contractile component due to TRPM8 activation. 
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Discussion 
The present study confirms that vasodilatory effects of menthol on pre-
constricted vascular rings (10, 17) are mediated via a direct inhibitory action on L-
type VGCCs. We thus refer to this effect as nonspecific if menthol is employed as 
pharmacological tool for the investigation of physiological effects of TRPM8 
activation.  When organ bath tensiometric experiments were performed on tail artery 
rings in the presence of nifedipine, TRPM8 agonist-induced vasodilatations were 
abolished indicating that these were a consequence of a direct inhibition of L-type 
VGCC activity. However, it should be noted that moderate contribution of 
endothelium to these relaxations was observed (17), and this likely holds true 
considering VGCC are lacking in endothelial cells, although further tests of 
endothelium involvement are now needed using experimental protocols we 
developed here for testing TRPM8 specific roles. However, in the present study the 
endothelium was removed to avoid this additional complexity.   
It is now well documented that menthol interacts with proteins other than 
TRPM8.  It has been shown that the compound can potently inhibit skeletal muscle 
and neuronal voltage-operated Na+ channels (15), neuronal and cardiac VGCCs (6, 
36) and now smooth muscle VSMCs ((10) and present study). These findings could 
be expected considering the similarity of vascular to cardiac muscle VGCC 
molecular composition (9). In addition, menthol has also been shown to activate 
TRPV3 at mM concentrations and bi-modally activate and inhibit TRPA1 in a 
concentration-dependent manner (18, 21). Millimolar concentrations have also been 
shown to induce Ca2+ release from the internal stores in non-TRPM8-expressing 
HEK293 cells (22).  Thus, in the present study a combination of a number of different 
TRPM8 agonists and selective TRPM8 antagonist AMTB were used to determine 
whether a specific and physiologically relevant TRPM8-mediated effect existed in tail 
artery VSMCs.     
In spite of its robust inhibitory effects on L-ICa, we show that menthol induces 
robust Ca2+-mobilising effects in tail artery VSMCs that were comparable with 
caffeine and PE.  In addition, at room temperature, menthol induced concentration-
dependent vasoconstrictions in the organ bath preparation.  Cheang et al. (10) noted 
that they did not observe vasoconstrictive effects of menthol in rat aorta, mesenteric 
artery or coronary artery at 37°C.  This is in agreement with our own observations 
(unpublished).  Menthol vasoconstrictions were only investigated in tail artery 
Commented [A1]: Moved below 
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vascular rings in the present study, and moreover, were larger and observed more 
consistently at room temperature. Clearly, the very complex interactions between 
voltage, menthol and temperature in TRPM8 activation (2, 14, 40) may explain these 
differences depending on temperature at which experiments are performed, as there 
is strong synergy between cooling and menthol (2, 15, 43). Indeed, according to 
Peier et al. (27) study, menthol was rather inefficient activator of TRPM8 at 35OC 
compared to 22OC. Interestingly, when experiments were performed in the presence 
of nifedipine, we were able to observe prominent menthol-induced vasoconstrictions 
in PE preconstricted arteries obviously masked by the inhibitory action of menthol on 
L-type Ca2+ currents described in previous studies (10, 17). In addition, menthol 
application to the organ bath while vascular rings were at basal tone also produced 
significant vasoconstrictions, though these were usually only observed when 
experiments were performed at room temperature. The observation that menthol-
induced vasoconstrictions became more pronounced at 37oC in the presence of PE 
(compare Fig. 8A and Fig. 3A) could be explained by several factors. First, we found 
significant colocalisation between TRPM8 and InsP3R1 (Fig. 5C). Since InsP3R 
activity is potentiated by [Ca2+]i rise it is possible that Ca2+ efflux via TRPM8 in its 
close vicinity potentiates PE-induced Ca2+ signalling via InsP3R. Second, TRPM8 
has been recently shown to activate Gq proteins directly, and thus it can synergise 
with α1-adrenoceptor in this same action (20). Third, although Ca2+ influx via  
TRPM8 makes prominent contribution to the menthol-induced Ca2+ responses (Fig. 
7A,B,E), one should not overlook the importance of Na+ influx, as TRPM8 is a 
nonselective cation channel primarily admitting Na+ under physiological gradients. 
Indeed, Na+ entry via the Na+-Ca2+ exchanger (NCX) facilitates Ca2+ entry via the 
NCX operating in the reverse mode, and this way it contributes to PE-induced [Ca2+]i 
oscillations and vasoconstriction. This mechanism becomes even more important in 
the presence of nifedipine (21), which is consistent with our observations assuming 
that TRPM-mediated Na+ entry facilitates Ca2+ entry via the reverse-mode of 
NCX.Mahieu et al. (22) described a TRPM8-independent menthol- mediated Ca2+ 
release observed in four different non-TRPM8 expressing cell-lines. In contrast to 
our observations however, the menthol responses observed by Mahieu et al., were 
temperature-dependent with large responses measured at 33°C, but only minor 
responses at room temperature, the opposite to our observations in rat tail artery 
smooth muscle. If the Ca2+-mobilising and vasocontrictive effects of menthol in the 
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present study were indeed a non-specific effect of the compound, it is reasonable to 
suggest that they would induce similar non-specific effects in other vascular beds. 
Menthol was applied to organ bath preparations of rat aorta, mesenteric artery and 
femoral artery vascular rings at both room temperature and 37°C, but had no effect 
on basal tone (data not shown). 
We found that menthol-induced vasoconstrictions in the presence of PE were 
mediated, at least in part, by Ca2+-release from the internal stores, since they were 
abolished by CPA pre-treatment which is known to deplete the Ca2+ store. Moreover, 
in the absence of the vasoconstrictive component of menthol’s action after Ca2+ 
store depletion, the vasodilatory effect of the compound was significantly greater. 
The involvement of TRPM8 in Ca2+ release is further supported by the localization of 
anti-TRPM8 immunofluorescence signals in close proximity to type I InsP3 receptors 
on intracellular structures analogous to SR (41) in immunocytochemistry 
experiments performed on isolated rat tail artery VSMCs. In mouse mesenteric artery 
myocytes, TRPM8 is also mainly localised in the cytosolic region (35). In menthol 
induced [Ca2+]i transients, the large initial transient component was also suggestive 
of predominant Ca2+ release contribution. 
Furthermore, a significant population of these intracellular TRPM8 channels 
showed colocalisation with type I InsP3 receptors, although it is possible that another 
part of intracellular TRPM8 staining simply represents synthesis and transport of 
TRPM8 proteins. Despite this uncertainty, in our Ca2+ confocal imaging experiments 
we obtained strong evidence for the contribution of both Ca2+ influx and Ca2+ release 
(the latter was evident after external Ca2+ removal) to [Ca2+]i rises induced by 
menthol, and we also found that menthol partially reduces the caffeine-releasable 
Ca2+ pool. In addition, ratiometric Ca2+ measurements showed significant reduction 
of menthol-induced Ca2+ transients following Ca2+ store depletion by CPA treatment. 
Taking together, these observations provide strong structural and functional 
evidence for the role of TRPM8 channels expressed in the SR. Notably, however, 
menthol (and WS-12) [Ca2+]i rises developed much more slowly compared to those 
initiated by PE (mainly via activation of InsP3 receptors) and caffeine (via activation 
of RyR receptors). This difference can in part be explained by slower diffusion of 
TRPM8 agonists into the cytosol, but it is more likely that lower expression of 
TRPM8 channels and/or the lack of their positive feedback activation by Ca2+, as is 
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the case for both InsP3 and RyR receptors, can account for such differences in 
kinetics. 
Furthermore, menthol-induced vasoconstrictions were significantly reduced in 
the presence of the selective TRPM8 antagonist AMTB, as an additional 
independent test of specificity.  Notably, the physiologically-relevant involvement of 
TRPM8 in Ca2+ release mediated by the intracellular (ER) TRPM8 channels has also 
been documented in other cells types, such as DRG neurons, normal prostate 
secretory epithelial cells, and in LNCaP cells, a prostate cancer cell-line (7, 8, 37, 39, 
44). 
While menthol has previously been shown to inhibit VGCCs, the present study 
is the first that we know of that describes inhibitory effects of icilin and WS-12 on L-
ICa.  Baylie et al. (6) did not observe any inhibitory effect of icilin on L-ICa at 
concentrations up to 100 µM in rabbit cardiac myocytes. The reason for this 
difference in L-VGCC inhibition by icilin may be any combination of, differences 
between the experimental conditions employed and species (e.g. rabbit vs. rat) or 
tissues studied. In the present study, electrophysiological experiments were 
performed at room temperature, while Baylie et al. recorded the effects of icilin on L-
ICa at 35°C. In addition to potential species and tissue-specific (vascular vs. cardiac) 
differences in L-VGCC subunit composition (e.g. in their α2δ- and β-subunits) and 
sequence variations, there is further possibility for variation of responses to 
pharmacological reagents due to tissue-specific alternative splicing resulting in 
altered channel structures (11, 19). Among the three TRPM8 agonists, WS-12 
appears to be the most selective one, at least it did not affect late component of L-ICa 
(although this was still inhibited to some extent by vehicle). Correspondingly, the 
vasorelaxation phase was absent when WS-12 was applied in the presence of PE. 
In conclusion, the TRPM8 agonist menthol has dual effects on vascular tone, 
normally resulting in a biphasic response (trace 1 in Fig. 11A). Menthol causes an 
endothelium-independent non-specific vasodilatory effect as a result of L-ICa 
inhibition, which could be “unmasked” by interrupting normal Ca2+ release (trace 2 in 
Fig. 11A), and a TRPM8-mediated vasoconstriction effect that was at least partly 
dependent on normal Ca2+ release, which could be “unmasked” under conditions in 
which VGCC activity was minimised (trace 3 in Fig. 11A).  We thus propose that 
TRPM8 is expressed and functional in rat tail artery VSM and that it is potentially 
localised both on the plasma membrane and the sarcoplasmic reticulum, the latter 
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predominantly functionally relevant,  as illustrated in our summary schematic model 
(Fig. 11B). Sun et al. (35) have recently provided evidence for beneficial effects of 
TRPM8 activation by menthol in hypertension treatment. Although much remains to 
be learned about the pathophysiology of TRPM8 activation by cold, environmental 
cold is a well-known risk factor for hypertension. Other conditions where the present 
findings may have translational implications include cardiovascular surgery, which is 
often performed at temperatures below 37O C, where TRPM8 can be activated, 
organ storage and transplantation, and Raynaud’s phenomenon. 
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Figure legends 
 
Figure 1  
Investigation of L-ICa in rat tail artery VSMCs indicates the existence of non-
inactivating “window” current in these cells and L-ICa inhibition by TRPM8 agonist, 
menthol.   
A - Representative recording of L-ICa in a rat tail artery VSMC, elicited by stepping 
the membrane potential to a range of prepulses (-100 to +40 mV with a 10 mV 
increment; 500 ms duration) from a holding potential of -60 mV to determine channel 
steady-state activation properties before stepping to +10 mV for 50 ms in order to 
determine the steady-state inactivation.  The upper panel shows the voltage 
protocol. 
B - Plotting activation and inactivation curves for the L-ICa demonstrated an overlap 
region whereby a small but persistent current exists, known as a “window” current.  
Inset: data from 8 cells (Cm=42.2±4.0 pF; n=8; N=4) were used to calculate mean 
“window” currents in tail artery VSMCs. 
C - Representative current traces showing the effects of menthol (300 µM) and the 
specific L-type VGCC blocker nifedipine (10 µM) on L-ICa in the same rat tail artery 
VSMC.  Currents were evoked by step depolarisation from -60 mV to +10 mV for 400 
ms, applied every 10 seconds. 
D - Example time-course showing the inhibitory effects of vehicle-only (0.3% ethanol) 
and menthol (300 µM) application on mean peak and late L-ICa in rat tail artery 
VSMCs (33.1±1.8 pF; n=8; N=3). 
E - Peak and late L-ICa were compared in individual cells in control conditions and in 
the presence of vehicle only (V; 0.3% ethanol) or menthol (M; 300 µM).  Both peak 
and late L-ICa in the presence of menthol were significantly reduced compared with 
their vehicle-only condition (P<0.001; n=8; N=3). 
F - Representative organ bath tensiometric trace showing that nifedipine, applied at 
the same concentration (10 μM) strongly suppresses the sustained component of the 
phenylephrine (2 μM)- evoked contraction, which is most likely mediated by the 
“window” L-ICa in rat tail artery VSMCs. 
 
 
Figure 2 
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TRPM8 agonists induced intracellular Ca2+ responses in rat tail artery VSMCs. 
A - Ratiometric Ca2+ recording of representative responses to caffeine (10 mM), PE 
(10 µM), and menthol (300 µM) with increases in F340/F380 ratio in a rat tail artery 
VSMC.  
B - Ratiometric Ca2+ recording of a representative rat tail artery VSMC responding to 
repeated applications of menthol (300 μM), followed by the application of caffeine (1 
mM), with increases in F340/F380 ratio. 
C - Summary data of the peak increases in F340/F380 in the presence of caffeine (1 
and 10 mM), phenylephrine (2 and 10 μM) and menthol (300 μM) relative to baseline 
ratio prior to applications. Student’s paired t-test was used to compare peak 
increases in ratio for each compound to mean baseline in the 30-60 seconds prior to 
application. 
D – Intracellular calcium responses recorded in the same myocytes were normalised 
to baseline and superimposed on the same time-scale to illustrate the differences in 
their 1-to90% rise-time, as illustrated for the menthol trace.  
C - Summary data of mean rise-times of [Ca2+]i responses to caffeine (10 mM, 
n=11), PE (10 μM, n=4) and menthol (300 μM, n=11). The Kruskal-Wallis non-
parametric ANOVA with Dunn‟s post hoc test was used to compare these values.  
 
 
Figure 3 
Menthol induces concentration-dependent vasoconstrictions in tensiometric 
recordings of tail artery vascular rings. 
A - Representative organ bath tensiometric traces showing concentration-dependent 
vasoconstrictions induced by menthol applications to rat tail artery vascular rings at 
room temperature. Inset, menthol-induced vasoconstrictions observed at 37°C were 
smaller in amplitude and more transient in appearance than those observed at room 
temperature. 
B – Bar chart summarising the peak amplitudes of menthol-induced 
vasoconstrictions relative to 60 mM KCl-induced vasoconstriction.  Menthol 
concentrations 0.3-1 mM were sufficient to induce vasoconstrictions that were 
consistently and significantly greater than baseline tone (one-way ANOVA, n=29; 
N=14).   
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Figure 4 
In the absence of VGCC activity, menthol induces vasoconstrictions in rat tail artery 
vascular rings. 
A - Representative tensiometric trace showing the predominant vasodilatory effect of 
menthol (300 µM) on PE-constricted rat tail artery vascular rings, which was 
suppressed while the constrictive effect was “unmasked” in the presence of the L-
type VGCC blocker, nifedipine (10 µM; n=22, N=13).  
 B - Bar chart summarising the effects of menthol on PE-vasoconstriction, causing an 
additional vasoconstriction (denoted Peak) followed by a later vasodilatory effect 
measured 10 minutes after menthol application (denoted Late), under control 
conditions and when nifedipine was applied 10 minutes prior to the application of PE.   
Summary data have been normalized to the PE-vasoconstriction amplitude 10 
minutes after PE application, as illustrated in the inset, namely: Peak = B/A; Late = 
C/A and expressed as % of PE-response before menthol application.  Values for 
each condition, i.e. PE after 10 minutes, menthol peak and after 10 minutes (Late) 
were then compared by one-way ANOVA for repeated measures followed by 
Tukey’s post hoc test.  Peak and late values in control conditions and in the 
presence of nifedipine were compared by Students t-test 
 
Figure 5 
Store-depletion in rat tail artery vascular rings abolished menthol-induced 
vasoconstrictions and potentiated menthol induced vasodilatations indicating TRPM8 
predominant functional localisation on the VSM SR, which was examined by 
immunocytochemistry. 
A - Representative trace showing the vasodilatory effect of menthol (300 µM) on PE 
(2 µM) vasoconstrictions of rat tail artery vascular rings (left panel, control) is 
amplified when CPA (10 µM) is applied 30 minutes prior to PE (n=8, N=8). 
B - Summary data showing that menthol-induced vasodilatations in the presence of 
CPA were significantly greater than in control conditions as determined by 
comparing the PE amplitude remaining 10 minutes after menthol application in both 
conditions (P<0.01, Student’s paired t-test; n=8, N=8).  
C - Representative cell (n=5, N=2) was fixed, blocked and permeabilised, and then 
incubated in Alomone anti-TRPM8 antibody (1:200) followed by Alexa 488 
34 
 
secondary antibody (1:200) and mounted in DAPI-containing medium. Left panel 
shows TRPM8 staining only. Middle panel shows a composite of TRPM8 and DAPI 
staining. Right panel shows a representative permeabilised cell, which was 
incubated only in the Alexa 488 secondary antibody (white lines = 20 μm). 
 
C – Confocal images of a representative rat tail artery myocyte co-labelled with 
Alomone anti-TRPM8 antibody (1:200, green channel) and anti-type I InsP3 receptor 
(InsP3R1) antibody (1:100, red channel) indicate both perimembrane and 
intracellular subcellular localisation of TRPM8, while the presence of many yellow 
pixels in the composite image indicates its significant colocalisation with InsP3R1. 
Fluorescence signals were normalised to maximum values for each channel to allow 
for differences in fluorescence intensity.  
 
Figure 6 
Ratiometric [Ca2+]i measurements in fura-2 AM loaded rat tail artery myocytes 
indicate that inhibition of VGCC has no effect, while Ca2+ store depletion strongly 
reduces the amplitude of menthol-induced [Ca2+]i transients in resting cells. 
A – In control, two consecutive menthol (300 μM) applications evoked reproducible 
[Ca2+]i rises.  
B – In cells treated for 5 min with the selective L-type Ca2+ channel blocker 
nicardipine (5 µM), the Ca2+ response to menthol was only marginally reduced. 
C - After calcium store depletion induced by CPA (10 µM) treatment for 5 min the 
menthol–induced Ca2+ transient  was decreased by about 50%, suggesting that  
Ca2+ release from the SR plays a significant role in the intracellular Ca2+ rise due to 
TRPM8 activation by menthol. 
D – Mean normalized to control response F340/F380 values summarizing the effects of 
VGCC inhibition (P=0.065, n=3) and Ca2+-store depletion (P=0.002, n=3) on 
menthol-evoked [Ca2+]i transients.  
 
Figure 7 
Laser-scanning confocal microscopy of Fluo-3 AM or Fluo4-AM loaded rat tail artery 
isolated myocytes indicates both Ca2+-influx and release in response to menthol 
application, as well as menthol-induced Ca2+ waves.  
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A – Time-course of Fluo-3 emitted fluorescence (detected with the MR-A1 system) in 
the region of interest (ROI, inset frame), while cell was challenged with two menthol 
(300 μM, denoted M) applications: first in normal-Ca2+ physiological salt solution (2 
mM; PSS); second in nominally Ca2+-free PSS, followed by caffeine (10 mM) 
application in the presence of menthol and still in nominally Ca2+-free PSS. Markers 
a-d indicates the time points of the frame series illustrated in C.  
B – in a similar to the illustrated in A experiment, but with caffeine application (10 
mM) after menthol (300 μM, denoted M), comparative larger caffeine-induced signal 
was observed, suggesting that menthol releases Ca2+ from the caffeine-sensitive 
pool, possibly via an additional Ca2+-induced Ca2+ release. 
C – Frame series show changes in intracellular Ca2+ (i.e. color-coded Fluo-3 
fluorescence signal intensity) during the different experimental conditions: a - control 
conditions in normal-Ca2+ PSS; b - in the presence of menthol (300 μM) in normal-
Ca2+ containing PSS; c - in the presence of menthol (300 μM) in nominally Ca2+-free 
PSS; d – following caffeine (10 mM) application in the presence of menthol (300 μM) 
in nominally Ca2+-free PSS. Note menthol-induced [Ca2+]i rises causing strong 
myocyte contraction. 
D – Confocal frame series showing the spatial dynamics of changes in intracellular 
Ca2+ in response to 300 μM menthol application (i.e. color-coded Fluo-4 
fluorescence signal intensity) acquired using the spinning Nipkow disc system at a 
rate of 33 frames per second in the same tail artery myocytes with (top panel) and 
without (bottom panel) Ca2+ in the external solution. 
E - Time-course of Fluo-4 emitted fluorescence recorded at site of Ca2+ signal 
initiation (blue line) and at the opposite side of the myocyte (black line) illustrated in 
panel D. 
 
 
Figure 8 
TRPM8 antagonist AMTB strongly inhibits menthol-induced vasoconstrictions of rat 
tail artery vascular rings, which were “unmasked” in the presence of the L-type 
VGCC blocker nifedipine. 
A - Representative tensiometric traces showing the effects of menthol (300 µM) on a 
PE-constricted rat tail artery vascular ring in the presence of nifedipine (10 µM) and 
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in the presence of both nifedipine (10 µM) and the TRPM8 antagonist AMTB (10 
µM).   
B - Summary data quantifying the effects of menthol when applied 10 minutes into a 
PE-vasoconstriction in control conditions, in the presence of nifedipine, and in the 
presence of nifedipine plus AMTB.  Summary data presented were normalized to the 
PE-vasoconstriction amplitude 10 minutes after PE application for each experimental 
condition (% control) as was already illustrated in Fig. 4B, left panel.  Menthol peak 
and late (after 10 minutes) % control values in the presence of nifedipine were 
significantly higher than those and in the presence of nifedipine and AMTB (peak: 
P<0.01; late: P<0.001; one-way ANOVA for repeated measures followed by Tukey’s 
post hoc test; n=9, N=9). 
 
Figure 9 
Investigation of L-ICa inhibition by icilin and WS-12 in rat tail artery VSMCs   
A - Representative current traces showing the effects of icilin (50 µM) and WS-12 
(50 µM) on the L-ICa in the same rat tail artery VSMC (same cell as in Fig. 1C).  
Currents were evoked by step depolarisation from -60 mV to +10 mV for 400 ms, 
applied every 10 s. 
B - Example time-course showing the inhibitory effects of vehicle-only (0.5% DMSO) 
and icilin (50 µM) application on mean peak and late L-ICa in rat tail artery VSMCs. 
C - Peak and late L-ICa were compared in individual cells in control conditions and in 
the presence of vehicle-only (0.5% DMSO; V) or icilin (50 µM; I).  Both peak and late 
L-ICa in the presence of icilin were significantly reduced compared with the vehicle-
only condition (P<0.001; n=8; N=3). 
D - Peak and late L-ICa were compared in individual cells in control conditions and in 
the presence of vehicle-only (0.5 % ethanol; V) or WS-12 (50 µM; W).  Peak L-ICa 
was significantly reduced in the presence of WS-12 compared with the vehicle-only 
condition (P<0.001; n=8; N=3). 
 
Figure 10 
The more selective TRPM agonist, menthol-derivative WS12, induces [Ca2+]i rises in 
single Fura-2 AM loaded rat tail artery myocytes and, in tensiometric recordings, 
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alters the balance between vasoconstriction and vasorelaxation towards 
predominant contraction. 
A - Ratiometric [Ca2+]i recording of a representative Fura-2-loaded VSMC that 
responded to caffeine (10 mM), PE (10 μM), WS-12 (10 μM) and menthol (300 μM) 
with increases in F340/F380 ratio.  
B - WS-12 induces vasoconstrictions in rat tail artery vascular rings both with and 
without VGCC activity. Representative tensiometric trace showing that WS-12 (50 
μM) had a predominantly vasoconstrictive effect (i.e. no net vasorelaxation phase 
was evident) on PE-constricted rat tail artery vascular rings that was potentiated in 
the presence of nifedipine (n=12, N=7). 
C - The bar chart on the left shows summary data quantifying the effects of WS-12 
when applied 10 minutes into a PE-vasoconstriction, causing a significant 
vasoconstriction (Peak) followed by a prolonged elevated tone measured 10 minutes 
after WS-12 application (Late, compared to menthol no relaxation was evident). The 
bar chart on the right shows summary data of similar measurements performed 
during incubation with nifedipine applied 10 minutes prior to the application of PE. 
Both Peak and Late responses were increased, suggesting that some “unmasking” 
of the contractile response in the absence of VGCC activity still takes place.      
 
Figure 11  
Normalised superimposed tensiometric traces demonstrating the effects of menthol 
on vascular tone under different experimental conditions and a schematic model of 
the probable underlying mechanisms. 
A - Demonstrative tensiometric traces showing representative effects of menthol in 
control conditions (1), and in the absence of either VGCC (2) or SR Ca2+ (3) 
involvement, as indicated.  Responses have been normalised to the tension 
observed 10 minutes after PE (2 µM) application in each experimental condition. In 
other words, traces were scaled such that at the moment of menthol application all 
three had the same amplitude, i.e. the level of tension after 10 minutes, just prior to 
the application of menthol represents 100% PE-induced contraction.  
B - Schematic mechanistic model showing the potential pathways by which the 
TRPM8 agonist menthol induces its multiple effects on vascular tone through the 
activation of the intracellular (major) and plasma membrane TRPM8 channels to 
cause vasoconstriction and through the inhibition of VGCC to cause vasorelaxation. 
